EX-99.1 2 a2024-q3ex991earnings.htm EX-99.1 Document
Exhibit 99.1
snbrlogojpg.jpg

FOR IMMEDIATE RELEASE

SLEEP NUMBER ANNOUNCES THIRD QUARTER 2024 RESULTS

COMPANY ALSO ANNOUNCES CHAIR, PRESIDENT AND CEO SHELLY IBACH TO RETIRE

Reported third quarter net sales of $427 million; delivered adjusted EBITDA of $28 million for the quarter which was consistent with expectations
Achieved gross margin rate of 60.8% for the third quarter, up 340 basis points versus last year, ahead of expectations and the highest quarterly gross margin rate since the third quarter of 2021
Reduced operating expenses by $17 million for the third quarter and $60 million year-to-date (before restructuring costs)
Increased year-to-date free cash flow by $50 million compared with the same period last year
Updated full-year 2024 adjusted EBITDA outlook to a revised range of $115 million to $125 million

MINNEAPOLIS – (October 30, 2024) – Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended September 28, 2024.

“Our actions throughout the business over the past year are driving sustainable operating model improvements and contributing to our increased financial flexibility and durability. Our initiatives drove broad cost efficiencies and a gross margin rate improvement to 60.8%, resulting in third quarter adjusted EBITDA of $28 million, which was in-line with expectations even with persistent consumer demand weakness,” said Shelly Ibach, Chair, President and CEO. “At the same time, we continue to leverage our innovation superiority to provide customers with life-changing sleep solutions, like our new ClimateCool™ smart bed.”

“Throughout my tenure, I have been inspired by our team’s commitment to our purpose, beloved brand, and pioneering smart beds that deliver proven quality sleep,” added Ibach. “As I transition to retirement, our talented team and strong competitive advantages, combined with our increased financial resilience, give me confidence in Sleep Number’s continued market leadership and its ability to accelerate profitable growth and value creation for all stakeholders when industry demand recovers.”

Third Quarter Overview

Net sales of $427 million were down 10% versus the prior year, including approximately two percentage points of pressure from year-over-year order backlog changes and one-point of pressure from lower store count versus the prior year
Gross margin of 60.8% was up 340 basis points versus the prior year, driven by year-over-year product cost reductions through value engineering and ongoing supplier negotiations, favorable product mix, and efficiency gains in our home delivery and logistics operations
Operating expenses of $249 million (before restructuring charges) were down $17 million versus the prior year’s third quarter, with year-to-date operating expenses down $60 million (before restructuring charges)
Adjusted EBITDA of $28 million was up 11% compared to the prior year, with an adjusted EBITDA margin of 6.5%, up 120 bp versus the prior year










Sleep Number Announces Third-quarter 2024 Results - Page 2 of 12    
Cash Flow Review

Net cash provided by operating activities of $51 million for the first nine months of the year, up $19 million, or 60%, versus the same period last year
Free cash flow of $34 million for the first nine months of the year, up $50 million versus the same period last year
Leverage ratio of 4.2x EBITDAR at the end of the third quarter versus covenant maximum of 5.0x for the quarter

Financial Outlook

With ongoing weakness in the bedding industry, the company has updated its full-year 2024 adjusted EBITDA outlook to a revised range of $115 million to $125 million. The company expects 2024 full-year net sales to be down approximately 10%, consistent with year-to-date net sales performance. The company’s outlook includes at least 150 basis points of gross margin rate improvement for the year. The company expects to generate $10 million to $20 million of free cash flow for the year with capital expenditures of approximately $25 million.

CEO Retirement and Board and Governance Changes

In a separate release today, the company announced the following:

Ibach to retire no later than the 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”), following a comprehensive search to identify her successor conducted by an independent executive search firm
Ibach will not stand for reelection to the Board at the 2025 Annual Meeting, at which time, the Board intends to appoint Michael J. Harrison as independent Chair of the Board
The Board intends to reduce its size, with two longer serving directors to retire at or before the 2026 Annual Meeting
The Board intends to amend the company’s governing documents, requesting shareholder approval at the 2025 Annual Meeting to begin a process to declassify the Board and adopt a majority voting standard for approval of mergers and amendments to the company’s Articles of Incorporation

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. We have also posted an updated investor presentation to the investor relations area of the Sleep Number website.






Sleep Number Announces Third-quarter 2024 Results - Page 3 of 12    
About Sleep Number Corporation

Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved nearly 16 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our more than 29 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,700 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in nearly 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number® store near you, our newsroom and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the statements that the company is driving sustainable operating model improvements and contributing to its increased financial flexibility and durability, continues to leverage its innovation superiority to provide customers with life-changing sleep solutions, and is positioned for continued market leadership and to accelerate profitable growth and value creation for all stakeholders when demand recovers; statements about the company’s financial outlook, including the company’s expected 2024 adjusted EBITDA and future net sales, demand, gross margin, and free cash flow expectations; and statements about its CEO and Board retirements and governance changes are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; (414) 732-9840; julie.elepano@sleepnumber.com





Sleep Number Announces Third-quarter 2024 Results - Page 4 of 12    

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
 
Three Months Ended
 September 28,
2024
% of
Net Sales
September 30,
2023
% of
Net Sales
Net sales$426,617 100.0 %$472,648 100.0 %
Cost of sales167,089 39.2 %201,537 42.6 %
Gross profit259,528 60.8 %271,111 57.4 %
Operating expenses:
Sales and marketing205,480 48.2 %221,143 46.8 %
General and administrative33,070 7.8 %31,948 6.8 %
Research and development10,583 2.5 %12,633 2.7 %
Restructuring costs1,963 0.5 %— 0.0 %
Total operating expenses251,096 58.9 %265,724 56.2 %
Operating income8,432 2.0 %5,387 1.1 %
Interest expense, net12,057 2.8 %10,958 2.3 %
Loss before income taxes(3,625)(0.8 %)(5,571)(1.2 %)
Income tax benefit(489)(0.1 %)(3,253)(0.7 %)
Net loss$(3,136)(0.7 %)$(2,318)(0.5 %)
Net loss per share – basic$(0.14) $(0.10) 
Net loss per share – diluted$(0.14) $(0.10) 
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding22,643  22,479  
Dilutive effect of stock-based awards—  —  
Diluted weighted-average shares outstanding22,643  22,479  

For the three months ended September 28, 2024 and September 30,2023, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.





Sleep Number Announces Third-quarter 2024 Results - Page 5 of 12    

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
 
 Nine Months Ended
September 28,
2024
% of
Net Sales
September 30,
2023
% of
Net Sales
Net sales$1,305,479 100.0 %$1,457,964 100.0 %
Cost of sales528,287 40.5 %612,343 42.0 %
Gross profit777,192 59.5 %845,621 58.0 %
Operating expenses:
Sales and marketing596,392 45.7 %649,410 44.5 %
General and administrative111,722 8.6 %111,144 7.6 %
Research and development34,602 2.7 %42,521 2.9 %
Restructuring costs14,382 1.1 %— 0.0 %
Total operating expenses757,098 58.0 %803,075 55.1 %
Operating income20,094 1.5 %42,546 2.9 %
Interest expense, net36,626 2.8 %30,008 2.1 %
(Loss) income before income taxes(16,532)(1.3 %)12,538 0.9 %
Income tax (benefit) expense(863)(0.1 %)2,637 0.2 %
Net (loss) income$(15,669)(1.2 %)$9,901 0.7 %
Net (loss) income per share – basic$(0.69) $0.44  
Net (loss) income per share – diluted$(0.69) $0.44  
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding22,588  22,412  
Dilutive effect of stock-based awards—  146  
Diluted weighted-average shares outstanding22,588  22,558  

For the nine months ended September 28, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.





Sleep Number Announces Third-quarter 2024 Results - Page 6 of 12    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Balance Sheets
(unaudited – in thousands, except per share amounts)
subject to reclassification
  
 September 28,
2024
December 30,
2023
Assets  
Current assets:
Cash and cash equivalents$1,592 $2,539 
Accounts receivable, net of allowances of $1,134 and $1,437, respectively
17,026 26,859 
Inventories93,039 115,433 
Prepaid expenses17,827 16,660 
Other current assets40,784 44,637 
Total current assets170,268 206,128 
Non-current assets:  
Property and equipment, net140,406 179,503 
Operating lease right-of-use assets367,133 395,411 
Goodwill and intangible assets, net66,468 66,634 
Deferred income taxes27,267 20,253 
Other non-current assets93,109 82,951 
Total assets$864,651 $950,880 
Liabilities and Shareholders’ Deficit  
Current liabilities:  
Borrowings under revolving credit facility$516,500 $539,500 
Accounts payable127,990 135,901 
Customer prepayments43,514 49,143 
Accrued sales returns19,688 22,402 
Compensation and benefits28,909 28,273 
Taxes and withholding17,685 17,134 
Operating lease liabilities82,488 81,760 
Other current liabilities57,268 61,958 
Total current liabilities894,042 936,071 
Non-current liabilities:
Operating lease liabilities318,665 351,394 
Other non-current liabilities100,728 105,343 
Total non-current liabilities419,393 456,737 
Total liabilities1,313,435 1,392,808 
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding
— — 
Common stock, $0.01 par value; 142,500 shares authorized, 22,371 and 22,235 shares issued and outstanding, respectively
224 222 
Additional paid-in capital25,527 16,716 
Accumulated deficit(474,535)(458,866)
Total shareholders’ deficit(448,784)(441,928)
Total liabilities and shareholders’ deficit$864,651 $950,880 






Sleep Number Announces Third-quarter 2024 Results - Page 7 of 12    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(unaudited – in thousands)
subject to reclassification
 
 Nine Months Ended
 September 28,
2024
September 30,
2023
Cash flows from operating activities:  
Net (loss) income$(15,669)$9,901 
Adjustments to reconcile net (loss) income to net cash provided by
   operating activities:
Depreciation and amortization50,379 55,196 
Stock-based compensation9,541 10,872 
Net loss on disposals and impairments of assets2,457 464 
Deferred income taxes(7,014)(13,433)
Changes in operating assets and liabilities:
Accounts receivable9,833 7,374 
Inventories22,394 (2,190)
Income taxes1,708 3,571 
Prepaid expenses and other assets(8,012)(5,903)
Accounts payable4,980 5,199 
Customer prepayments(5,629)(27,279)
Accrued compensation and benefits788 (6,923)
Other taxes and withholding(1,157)
Other accruals and liabilities(13,775)(5,038)
Net cash provided by operating activities50,824 31,816 
Cash flows from investing activities:
Purchases of property and equipment(17,218)(48,022)
Proceeds from sales of property and equipment156 10 
Issuance of notes receivable(2,942)(1,317)
Net cash used in investing activities(20,004)(49,329)
Cash flows from financing activities:
Net (decrease) increase in short-term borrowings(31,039)20,334 
Repurchases of common stock(728)(3,711)
Proceeds from issuance of common stock— 428 
Net cash (used in) provided by financing activities(31,767)16,627 
Net decrease in cash and cash equivalents(947)(886)
Cash and cash equivalents, at beginning of period2,539 1,792 
Cash and cash equivalents, at end of period$1,592 $906 






Sleep Number Announces Third-quarter 2024 Results - Page 8 of 12    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Supplemental Financial Information
(unaudited)
 
 Three Months EndedNine Months Ended
 September 28,
2024
September 30,
2023
September 28,
2024
September 30,
2023
Percent of sales:    
Retail stores87.8 %86.6 %87.9 %87.1 %
Online, phone, chat and other12.2 %13.4 %12.1 %12.9 %
Total Company100.0 %100.0 %100.0 %100.0 %
Sales change rates:
Retail comparable-store sales(7 %)(14 %)(9 %)(11 %)
Online, phone and chat(18 %)(14 %)(17 %)(13 %)
Total Retail comparable sales change(9 %)(14 %)(10 %)(11 %)
 Net opened/closed stores and other
(1 %)%%%
Total Company(10 %)(13 %)(10 %)(10 %)
Stores open:
Beginning of period646 672 672 670 
Opened11 27 
Closed(4)(2)(40)(19)
End of period643 678 643 678 
Other metrics:
Average sales per store ($ in 000's) 1
$2,670 $2,952 
Average sales per square foot 1
$863 $963 
Stores > $2 million net sales 2
60 %67 %
Stores > $3 million net sales 2
20 %27 %
Average revenue per smart bed unit 3
$5,771 $5,640 $5,778 $5,822 

1 Trailing twelve months Total Retail comparable sales per store open at least one year.
2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.





Sleep Number Announces Third-quarter 2024 Results - Page 9 of 12    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation, restructuring costs and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:
 Three Months EndedTrailing Twelve Months Ended
 September 28,
2024
September 30,
2023
September 28,
2024
September 30,
2023
Net (loss) income$(3,136)$(2,318)$(40,857)$4,471 
Income tax (benefit) expense(489)(3,253)(7,966)1,346 
Interest expense12,057 10,958 49,313 37,641 
Depreciation and amortization15,859 18,200 67,335 72,338 
Stock-based compensation1,432 982 13,523 15,511 
Restructuring costs 1
1,963 — 30,110 — 
Asset impairments— 292 198 491 
Adjusted EBITDA$27,686 $24,861 $111,656 $131,798 


1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.


Free Cash Flow
(in thousands)

 Nine Months EndedTrailing Twelve Months Ended
 September 28,
2024
September 30,
2023
September 28,
2024
September 30,
2023
Net cash provided by (used in) operating activities
$50,824 $31,816 $9,980 $(12,168)
Subtract: Purchases of property and equipment17,218 48,022 26,252 64,668 
Free cash flow$33,606 $(16,206)$(16,272)$(76,836)
 

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.





Sleep Number Announces Third-quarter 2024 Results - Page 10 of 12    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Net Leverage Ratio under Revolving Credit Facility
(in thousands)

Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the November 2, 2023 amendment are presented below. The prior year is presented in conformity with the November 2, 2023 amendment.
 
 Trailing Twelve Months Ended
 September 28,
2024
September 30,
2023
Borrowings under revolving credit facility$516,500 $488,000 
Outstanding letters of credit7,147 7,147 
Finance lease obligations261 338 
Consolidated funded indebtedness$523,908 $495,485 
Operating lease liabilities 1
401,153 439,722 
Total debt including operating lease liabilities (a)$925,061 $935,207 
Adjusted EBITDA (see above)$111,656 $131,798 
Consolidated rent expense108,863 113,204 
Consolidated EBITDAR (b)$220,519 $245,002 
Net Leverage Ratio under revolving credit facility (a divided by b)4.2 to 1.03.8 to 1.0
1Reflects operating lease liabilities included in our financial statements under ASC 842. The prior period has been updated to reflect this calculation.


Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.








Sleep Number Announces Third-quarter 2024 Results - Page 11 of 12    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Return on Invested Capital (Adjusted ROIC)
(in thousands)
 
Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

 Trailing Twelve Months Ended
 September 28,
2024
September 30,
2023
Adjusted net operating profit after taxes (Adjusted NOPAT)  
Operating income$490 $43,458 
Add: Operating lease interest 1
27,371 27,497 
Less: Income taxes 2
(5,474)(1,168)
Adjusted NOPAT$22,387 $69,787 
  
Average adjusted invested capital
Total deficit$(448,784)$(420,687)
Add: Long-term debt 3
516,761 488,338 
Add: Operating lease liabilities 4
401,153 439,722 
Total adjusted invested capital at end of period$469,130 $507,373 
  
Average adjusted invested capital 5
$502,494 $469,782 
  
Adjusted ROIC 6
4.5 %14.9 %
1
Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.
2
Reflects annual effective income tax rates, before discrete adjustments, of 19.6% and 1.6% for September 28, 2024 and September 30, 2023, respectively.
3
Long-term debt includes existing finance lease liabilities.
4
Reflects operating lease liabilities included in our financial statements under ASC 842.
5
Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.
6
Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.
Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842.
GAAP - generally accepted accounting principles in the U.S.






Sleep Number Announces Third-quarter 2024 Results - Page 12 of 12    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Reported to Adjusted Statements of Operations Data Reconciliation
(in thousands, except per share amounts)


Three Months Ended
September 28, 2024September 30, 2023
As
Reported
Restructuring Costs 1,2
As
Adjusted
As
Reported
Operating income$8,432 $1,963 $10,395 $5,387 
Interest expense, net12,057 — 12,057 10,958 
Loss before income taxes(3,625)1,963 (1,662)(5,571)
Income tax (benefit) expense(489)465 (24)(3,253)
Net loss$(3,136)$1,498 $(1,638)$(2,318)
Net (loss) income per share:
Basic$(0.14)$0.07 $(0.07)$(0.10)
Diluted$(0.14)$0.07 $(0.07)$(0.10)
Basic Shares22,643 22,643 22,643 22,479 
Diluted Shares22,643 22,643 22,643 22,479 

Nine Months Ended
September 28, 2024September 30, 2023
As
Reported
Restructuring Costs 1,2
As
Adjusted
As
Reported
Operating income$20,094 $14,382 $34,476 $42,546 
Interest expense, net36,626 — 36,626 30,008 
(Loss) income before income taxes(16,532)14,382 (2,150)12,538 
Income tax (benefit) expense(863)3,409 2,546 2,637 
Net (loss) income$(15,669)$10,973 $(4,696)$9,901 
Net (loss) income per share:
Basic$(0.69)$0.49 $(0.20)$0.44 
Diluted$(0.69)$0.49 $(0.20)$0.44 
Basic Shares22,588 22,588 22,588 22,412 
Diluted Shares22,588 22,588 22,588 22,558 


1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.
2 The income tax expense is calculated using the estimated U.S. federal and state statutory tax rate of 23.7%.

Note - Our "as adjusted" data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates year-over-year comparisons for investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.